Skip to content
MARKETS / NASDAQ / TNDM
NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · LARGE CAP

Tandem Diabetes Care Inc. TNDM

14 fiscal years on record · USD · FY2025 reported · SEC filings only
$1.0B
▲ 7.9% YoY
$-204.7M
$-29.7M
▼ 694.1% YoY
In brief

What this company does

Tandem Diabetes Care, Inc. offers durable insulin pumps designed for years of daily use, together with single-use supplies that are replaced every few days. It serves nearly 500,000 people living with diabetes in more than 25 countries worldwide. Its Tandem pump platforms include t:slim X2 and Tandem Mobi, both of which feature Control-IQ+ advanced hybrid closed-loop technology. Its insulin pumps are assembled, tested, and packaged at its facilities in San Diego, California. As of December 31, 2025, it had approximately 2,500 regular full-time employees, who primarily work in the United States, Canada, or Europe. Its headquarters are in San Diego, California, where its primary research and development and administrative functions are located, and where it also operates a manufacturing facility and a warehousing facility.

Written from the business description in Tandem Diabetes Care, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 19 February 2026. Every sentence was checked against that document before publication.

Growth
USD 1.0B
Revenue, FY2025 · full 14-year series below
Revenue $B Net income $B
FY2025 · Revenue 1.0 · Net income -0.2
0.40B0.80B-0.08B-0.16B20122014201620182020202220242025
Compound annual growth
+8.2%
+15.3%
+30.1%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +15.3% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−20 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -18.5% · Net -20.2%
-500%-1000%20122014201620182020202220242025
ROE
FY2025 · ROE -97.9%
-500%-1000%20122014201620182020202220242025

Each USD of equity lost 98 cents this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -29.7
40.0M80.0M-25.0M-50.0M20122014201620182020202220242025
Net buybacks $M Dividends $M
FY2025 · Dividends — · Net buybacks 0.0
8M16M-8M-16M2022202320242025

Total assetsUSD 881.1M
EquityUSD 155.2M
CashUSD 90.6M
Gross debtUSD 310.0M
Net debtUSD 219.4M
Current ratio2.55×

Net debt stands at 141% of equity.

The 14-year record
14 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 20252024202320222021202020192018201720162015201420132012
Revenue $B1.00.90.70.80.70.50.40.20.10.10.10.00.00.0
Operating income $B−0.2−0.1−0.2−0.10.0−0.0−0.0−0.0−0.1−0.1−0.1−0.1−0.0−0.0
EBITDA $B−0.2−0.1−0.2−0.10.00.0−0.0−0.0−0.1−0.1−0.1−0.1−0.0−0.0
Income tax $B0.00.00.00.00.0−0.00.00.00.0−0.00.00.0··
Net income $B−0.2−0.1−0.2−0.10.0−0.0−0.0−0.1−0.1−0.1−0.1−0.1−0.1−0.0
Free cash flow $B−0.00.0−0.10.00.1−0.00.0−0.0−0.1−0.1−0.1−0.1−0.1−0.0
EPS, diluted $−3.04−1.47−3.43−1.470.24−0.56−0.42−2.55−12.87−27.30−25.04−3.42−21.46−175.88
Dividend / sh $··············
Payout %··············
ROE %−97.9−33.3−59.1−21.73.9−12.3−15.2−240.1·−290.0−122.7−93.5−1331.3·
Shares out B0.070.070.070.060.060.060.060.060.010.000.030.020.02·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 68 reconciliationsAUDITED

Reconciled in 14 of 19 fiscal years. 27 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivitySurgical & Medical Instruments & Apparatus
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2012

Share this section

Download image